Vitamin D, used in MS treatment, can increase the activity and the production of G6PD.12-14 This can possibly explain the protective impact of vitamin D against oxidative stress.15 Considering G6PD’s protective role against oxidative damage as well as its role in myelin production, its deficiency may exist in MS and NMO. Here, G6PD is linked to myeloid sarcoma.